These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33682555)

  • 81. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
    Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
    Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years.
    Keene DJ; Mistry D; Nam J; Tutton E; Handley R; Morgan L; Roberts E; Gray B; Briggs A; Lall R; Chesser TJ; Pallister I; Lamb SE; Willett K
    Health Technol Assess; 2016 Oct; 20(75):1-158. PubMed ID: 27735787
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cost-Effectiveness of One-Time Birth Cohort Screening for Hepatitis C as Part of the National Health Service Health Check Program in England.
    Williams J; Miners A; Harris R; Mandal S; Simmons R; Ireland G; Hickman M; Gore C; Vickerman P
    Value Health; 2019 Nov; 22(11):1248-1256. PubMed ID: 31708061
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis.
    Rodgers M; Marshall D; Simmonds M; Le Couteur A; Biswas M; Wright K; Rai D; Palmer S; Stewart L; Hodgson R
    Health Technol Assess; 2020 Jul; 24(35):1-306. PubMed ID: 32686642
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups.
    Beswick AD; Rees K; Griebsch I; Taylor FC; Burke M; West RR; Victory J; Brown J; Taylor RS; Ebrahim S
    Health Technol Assess; 2004 Oct; 8(41):iii-iv, ix-x, 1-152. PubMed ID: 15461879
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation.
    Grant SW; Sperrin M; Carlson E; Chinai N; Ntais D; Hamilton M; Dunn G; Buchan I; Davies L; McCollum CN
    Health Technol Assess; 2015 Apr; 19(32):1-154, v-vi. PubMed ID: 25924187
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Implementing a national diabetes prevention programme in England: lessons learned.
    Stokes J; Gellatly J; Bower P; Meacock R; Cotterill S; Sutton M; Wilson P
    BMC Health Serv Res; 2019 Dec; 19(1):991. PubMed ID: 31870371
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The English national health service diabetes prevention programme (NHS DPP): A scoping review of existing evidence.
    Whelan M; Bell L
    Diabet Med; 2022 Jul; 39(7):e14855. PubMed ID: 35441747
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Headroom Analysis for Early Economic Evaluation: A Systematic Review.
    Boudewijns EA; Otten TM; Gobianidze M; Ramaekers BL; van Schayck OCP; Joore MA
    Appl Health Econ Health Policy; 2023 Mar; 21(2):195-204. PubMed ID: 36575333
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model.
    McManus E
    Pharmacoecon Open; 2024 Jul; 8(4):569-583. PubMed ID: 38643282
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme.
    Frempong SN; Shinkins B; Howdon D; Messenger M; Neal RD; Sagoo GS
    Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):417-427. PubMed ID: 33682555
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis.
    Ravindrarajah R; Sutton M; Reeves D; Cotterill S; Mcmanus E; Meacock R; Whittaker W; Soiland-Reyes C; Heller S; Bower P; Kontopantelis E
    PLoS Med; 2023 Feb; 20(2):e1004177. PubMed ID: 36848393
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.